Immune Response

Understanding immune response requires deep insight -
Gain fresh perspective on T cell specificity and function

Collaboration with Genentech

Bystander CD8+ cells are abundant and phenotypically distinct in human tumour infiltrates

Come see us at SITC annual meeting
previous arrow
next arrow
Slider

Enabling Immunotherapy

immunoSCAPE will support your immunotherapy clinical development by measuring treatment and outcome-associated changes in antigen-specific T cells and patient immune response.

Our Technology

High-Dimensional Immune Profiling

High-dimensional immune cell profiling technologies have become indispensable for creating maps that help navigate how immunotherapy affect the immune response in cancer, autoimmune, and infectious diseases.

targetSCAPE

immunoSCAPE's unique technology for high-dimensional antigen-specific T cell identification and profiling. T cells are key effector cells in the fight against tumors and some infectious agents. Often, they are mediators of immunotherapy biological activity and vaccine protection. They can also drive or contribute to pathogenic immune responses in autoimmune diseases such as rheumatoid arthritis, type I diabetes, psoriasis.

CYTOGRAPHER®

CYTOGRAPHER® is immunoSCAPE’s online analytical pipeline to produce deep insight into your biological questions.

Testimonials

I consider immunoSCAPE a strong partner for understanding immune response. I am impressed with the data from their high throughput screening of antigen specificity.
Dr Mahesh Yadav, Genentech
immunoSCAPE is a strong partner for us. I consider my relationship with immunoSCAPE as a strategic alliance based on immunoSCAPE's scientific expertise and its strength as an innovative collaborator.
Dr Melvin Chua, Senior Consultant and Clinician-Scientist, National Cancer Centre Singapore
immunoSCAPE is a great partner for us. They have excellent technical expertise and feedback outstanding data. I am super impressed with their work and have a fantastic working relationship with the team.
Dr Al Leslie, Principal Investigator, Africa Health Research Institute

Latest News